MRA Grant Mechanisms
MRA supports both individual investigator and collaborative team projects focused on translational, innovative research that will impact the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future. Since its founding, MRA has provided over $100 million for melanoma research.
Young Investigator Awards
aim to attract early career scientists with novel ideas into melanoma research, thereby recruiting and supporting the next generation of melanoma researchers. Young Investigators are scientists within four years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.
test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.
Established Investigator Awards
support senior investigators with an established record of scientific productivity and accomplishment and who are past the initial four years of their first academic faculty appointment.
Team Science Awards
are the centerpiece of the MRA research funding portfolio. This program fulfills one of MRA’s primary goals: to foster a collaborative research process. Multidisciplinary teams consist of Principal Investigators with complementary expertise who may be from the same institution, inter-institutional, and/or international institutions. Team science projects promote transformational melanoma research advances with the potential for rapid clinical translation.
are designed to facilitate interactions between sectors including industry and other nonprofit organizations.
The Melanoma Research Alliance, the largest non-profit funder of melanoma research worldwide, is committed to ending death and suffering due to melanoma. Learn more about MRA.